companydata.dkcompanydata.dk

BioTesch Holding ApS: Financial statements 2022

CVR: 39660350

Source: annual report 2022, Danish Business Authority

01/07/2021 – 30/06/2022

BioTesch Holding ApS (CVR 39660350) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -48,509 and a net result of DKK -355,406 compared with DKK 234,118 the year before. Equity in the 2022 report amounted to DKK 4,902,589. The solvency ratio was 99.6%.

Revenue
DKK 0
Gross Profit
DKK -48,509
Profit/Loss
DKK -355,406
Equity
DKK 4,902,589
Total Assets
DKK 4,921,791

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20220-49 t.-355 t.4.9 mio.-
20210-64 t.234 t.5.3 mio.-
2020--60 t.143 t.4.5 mio.-
2019--10 t.-161 t.1.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on BioTesch Holding ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About BioTesch Holding ApS

BioTesch Holding ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2018. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Anker Gunvald Lundemose. The company is owned by Anker Gunvald Lundemose and SWAL APS. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -47,056 and a net result of DKK -239,948 compared with DKK -1,252,298 the year before. Equity in the 2026 report amounted to DKK 3,321,060.

Source: annual report 2026, Danish Business Authority

Other financial years